Current Funding Opportunities

Through our research program, Komen awards grants to support cutting-edge breast cancer research that will provide the greatest benefit to patients. We’re focused on conquering metastatic and aggressive breast cancers, advancing personalized breast care and eliminating breast cancer disparities and inequities. Our goal is to improve breast health care and outcomes for everyone and save lives.

Each year, we release Request for Applications (RFA) to communicate which grant mechanisms and scientific focus areas are available for funding. The types of mechanisms and the scientific focus areas may vary from year to year. Our latest research funding opportunities are available below!

Komen Application and Review Process

Susan G. Komen® utilizes a multi-step approach to grant application and review that first requires limited submission of a Letter of Intent (LOI) and upon invitation only, submission of an Application.  Applicants/Primary Investigators (PIs) will be notified of LOI review decisions via email. Applicants/PIs invited to submit an Application will then be granted access to the Application site in proposalCENTRAL.  

All institutions must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants. A copy of the latest version of these awards is found with the other documents for the LOI or Application in proposalCENTRAL. 

Susan G. Komen Career Catalyst Research (CCR) Grants

The 2026-2027 Career Catalyst Research (CCR) Grant funding cycle is now closed. Applicants will be notified of intent to fund on or around April 15, 2027.

Please check back in June 2027 for information about the next funding opportunity and application timeline.

Susan G. Komen Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC

The 2026-2027 Inflammatory Breast Cancer (IBC) Research Grant funding cycle is open.

Click on this topic below to learn more about the funding opportunity.

Letter of Intent (LOI) Announcement

LOI Announcement Release Date: September 28, 2026
Institution Opt-in Deadline: October 9, 2026
LOI Submission Deadline: November 30, 2026, by 1:00 pm EST
Invitation to Submit an Application: by December 8, 2026
Full Application Deadline: January 18, 2027

About the Grant: The Inflammatory Breast Cancer (IBC) Research Grant will support research projects that aim to unlock new knowledge about the biological mechanisms driving inflammatory breast cancer (IBC), stimulating the exploration of new ideas and areas of investigation with significant potential to improve IBC patient care and outcomes.

IBC Grant Terms: Applicants/Primary Investigators (PIs) may request funding of up to $125,000 (combined direct and indirect costs) for one year.

IBC Limited Submission Nomination Process: Institutions must respond to SSPrograms@komen.org by October 9, 2026, to indicate that they are opting in to the institutional nomination process.

This is a limited submission opportunity: each institution may submit ONE nominee to apply for this funding. Applicant/PI cannot self-nominate. The Institution’s Office of Sponsored Programs, Grants Office, or equivalent must select the nominees to apply for this funding.

IBC Eligibility: U.S.- based independent investigators working at non-profit institutions and organizations. Researchers with a formal offer letter that confirms an independent position and start date by the Full Application due date (January 18, 2027) are also eligible. Applicant may NOT be the PI of an active Komen Grant that includes specific aims or objectives focused on IBC at the Full Application due date. Applicants may NOT be the PI of two or more active Komen Grants at the Full Application due date.

RFA Focus Area: This grant mechanism supports outstanding research with a specific primary focus on inflammatory breast cancer (IBC). We are especially interested in hypothesis-driven studies that will expand our understanding of the biology of IBC, as it relates to IBC onset and development, metastatic dissemination or monitoring and detection. To accelerate transformative advances in the understanding of IBC biology, we encourage applicants to build ground-breaking paradigms, test imaginative hypotheses and develop creative concepts that could shift the current prevailing theories and scientific perspectives around IBC. Projects that use preliminary data or other compelling evidence to support new avenues of investigation are especially well aligned with this funding mechanism, particularly when they have the potential to inform future larger-scale studies.

Download the current Susan G. Komen Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC LOI Announcement for more details.

Review Process: Susan G. Komen® utilizes a multi-step approach to grant application and review that first requires submission of a Letter of Intent and upon invitation only, submission of an Application.

Applicants/PIs will be notified of Letter of Intent review decisions via email by December 8, 2026. Applicants/PIs invited to submit a Full Application will then be provided with Full Application Instructions.

All institutions and industry partners must agree to adhere to Komen’s Policies and Procedures for Research and Training Grants.